Name
I-FABP, Human, pAb
Catalog nr
HP9020 (lot number and expiry date are indicated on the label)
Short description
The polyclonal antibody recognizes human intestinal fatty acid binding protein (I-FABP) of both natural and recombinant origin. The I-FABP protein is derived from the human FABP2 gene. FABPs are small intracellular proteins (~13-14 kDa) with a high degree of tissue specificity that bind long chain fatty acids. They are abundantly present in various cell types and play an important role in t...
Size
100 µg
Application
IA , W
Technical datasheet
Description
The polyclonal antibody recognizes human intestinal fatty acid binding protein (I-FABP) of both natural and recombinant origin. The I-FABP protein is derived from the human FABP2 gene. FABPs are small intracellular proteins (~13-14 kDa) with a high degree of tissue specificity that bind long chain fatty acids. They are abundantly present in various cell types and play an important role in the intracellular utilization of fatty acids, transport and metabolism. There are at least nine distinct types of FABP, each showing a specific pattern of tissue expression. Due to its small size, FABP leaks rapidly out of ischemically damaged necrotic cells leading to a rise in serum levels. Ischemically damaged tissues are characterized histologically by absence (or low presence) of FABP facilitating recognition of such areas. I-FABP is localized in the small bowel epithelium, with highest expression level in the jejunum.
Cross Reactivity
 Cross reactant  Reactivity
 Mouse  Yes
 Rat  Yes
 Sheep  Yes
 Swine  Yes
Formulation
1 ml (100 µg/ml) 0.2 µm filtered antibody solution in PBS, containing 0.1% bovine serum albumin and 0.02% sodium azide.
Species
Rabbit IgG
Application

F

FC

FS

IA

IF

IP

P

W

Yes

No

N.D.

N.D. = Not Determined; F = Frozen sections; FC = Flow Cytometry; FS = Functional Studies; IA = Immuno Assays; IF = Immuno Fluorescence; IP = Immuno Precipitation; P = Paraffin sections; W = Western blot

Use
For immunohistology and Western blotting, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.
Aliases
FABP2, FABPI
Storage and stability
Product should be stored at 4°C. Under recommended storage conditions, product is stable for one year.
References
  1. Kanda, T et al; Intestinal fatty acid-binding protein is available for diagnosis of intestinal ischaemia; immunochemical analysis of two patients with ischaemic intestinal diseases. Gut 1995, 36: 788
  2. Kanda, T et al; Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996, 110: 339
  3. Morissey, P et al; Small bowel allograft rejection detected by serum intestinal fatty acid-binding protein is reversible. Transplantation 1996, 61: 1451
  4. Lieberman, J et al; Human intestinal fatty acid binding protein: Report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 1997, 121: 335
Precautions
For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result with the use or derivation of this product.
Also available
References
  1. Kanda, T et al; Intestinal fatty acid-binding protein is available for diagnosis of intestinal ischaemia; immunochemical analysis of two patients with ischaemic intestinal diseases. Gut 1995, 36: 788
  2. Kanda, T et al; Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996, 110: 339
  3. Morissey, P et al; Small bowel allograft rejection detected by serum intestinal fatty acid-binding protein is reversible. Transplantation 1996, 61: 1451
  4. Lieberman, J et al; Human intestinal fatty acid binding protein: Report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 1997, 121: 335